Enzyme replacement therapy in Japanese Fabry disease patients: The results of a phase 2 bridging study

Overview of attention for article published in Journal of Inherited Metabolic Disease, June 2003

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 62 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Migalastat for treating Fabry disease: Committee papers

Cited by National Institute for Health and Care Excellence on 18 Oct 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Morbus Fabry, Diagnose und Therapie: Langfassung der Leitlinie "Morbus Fabry, Diagnose und Therapie"

Cited by The Association of the Scientific Medical Societies in Germany on 30 Jun 2013

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.